BioSyent (CVE:RX) Stock Price Crosses Above Fifty Day Moving Average – What’s Next?

BioSyent Inc. (CVE:RX) shares passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$11.35 and traded as high as C$11.43. BioSyent shares last traded at C$11.43, with a volume of 100 shares changing hands.

BioSyent Stock Down 2.3 %

The company has a market capitalization of C$129.46 million, a PE ratio of 18.62 and a beta of 0.93. The firm’s 50-day simple moving average is C$11.36 and its 200 day simple moving average is C$10.80. The company has a debt-to-equity ratio of 3.19, a quick ratio of 6.91 and a current ratio of 6.13.

Insiders Place Their Bets

In related news, insider FAX Capital Corp. sold 230,800 shares of the business’s stock in a transaction dated Friday, November 22nd. The shares were sold at an average price of C$11.12, for a total value of C$2,566,496.00. Also, Senior Officer Robert Joseph March sold 4,775 shares of the business’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of C$11.65, for a total transaction of C$55,628.75. In the last ninety days, insiders have sold 349,144 shares of company stock worth $3,903,370. Corporate insiders own 33.65% of the company’s stock.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.